Narrative Enhancement and Cognitive Therapy for Self-Stigma in Youth
A Randomized Pilot Basket Trial of Discovering Our Best Selves: Narrative Enhancement and Cognitive Therapy for Self-stigma Among Youth
1 other identifier
interventional
96
1 country
1
Brief Summary
The goal of this pilot clinical trial is to assess the feasibility of conducting a full-scale study to learn if a new youth-adapted Narrative Enhancement and Cognitive Therapy (NECT-Y) reduces self-stigma in youth living with bipolar disorder or multiple mental health conditions. The main questions it aims to answer are:
- What is the feasibility of conducting a definitive clinical trial in terms of recruitment success, study retention/compliance, treatment retention/compliance, and absence of serious adverse events?
- Can facilitators deliver the adapted NECT-Y intervention with fidelity?
- What is the acceptability of the newly adapted NECT-Y intervention among youth participants and facilitators? Researchers will compare NECT-Y to treatment as usual (TAU). Participants will take part in a virtual 14-week NECT-Y group intervention or receive TAU. They will also complete questionnaires at three time points (baseline, post-treatment, and follow-up).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Nov 2024
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 1, 2024
CompletedStudy Start
First participant enrolled
November 1, 2024
CompletedFirst Posted
Study publicly available on registry
November 4, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
April 1, 2026
CompletedNovember 4, 2024
November 1, 2024
1.1 years
November 1, 2024
November 1, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (8)
Number of Participants Providing Consent to Participate in the Study
Our study target is \> 60% of individuals approached/contacted will consent to participate in the study.
Duration of the study enrollment period, up to 1 year
Number of Participants Providing Consent in Two Months
The study target is to obtain study consent from 24 participants in two months.
Duration of the study enrollment period, up to 1 year
Number of Sessions Attended by Participants Randomized to NECT-Y
The study target is that participants randomized to NECT-Y attend \> 80% of the 14 sessions.
From week 1 to week 14 of the NECT-Y intervention, up to 14 weeks
Number of Participants Completing Study Questionnaires at Week 15
The study target is \> 80% of the participants complete at least one questionnaire at post-treatment (week 15).
Week 15 (post-treatment)
Number of Participants Completing Study Questionnaires at Week 28
The study target is \> 80% of the participants complete at least one questionnaire at 3-month follow up (week 28).
Week 28 (3-month follow up)
Number of Questionnaires Completed at Week 15
The study target is participants complete \> 90% of the 14 questionnaires at post-treatment (week 15).
Week 15 (post-treatment)
Number of Questionnaires Completed at Week 28
The study target is participants complete \> 90% of the 14 questionnaires at 3-month follow up (week 28).
Week 28 (3-month follow up)
Number of Participants With Study-Related Adverse Events as Assessed by an Institutional Adverse Event Log
The study target is for their to be no adverse events throughout a participants enrollment in the study, including no AEs from participating in the NECT-Y intervention. AEs will be tracked ad hoc as participants self-report any AEs.
From study enrollment to 3-month follow up, up to 28 weeks
Secondary Outcomes (3)
Was NECT-Y Acceptable to Youth Participants?
~ Week 15 (2-hour focus group)
Was NECT-Y Acceptable to Co-Facilitators?
~ Week 28 (1-hour interview)
Was NECT-Y Delivered With Fidelity in Relation to the Intervention Manual as Assessed by a Standardized Fidelity Scale?
From week 1 to week 14 of the NECT-Y intervention, up to 14 weeks
Other Outcomes (2)
Change from Baseline in the Mean Self-Stigma at Week 15 (post-treatment)
baseline, 15 weeks
Change from Baseline in the Mean Self-Stigma at Week 28 (3-Months Follow-up)
baseline, 28 weeks
Study Arms (2)
NECT-Y
EXPERIMENTALVirtual 14-week Narrative Enhancement and Cognitive Therapy group intervention that will be co-facilitated by a clinician and peer support worker.
Treatment as usual
PLACEBO COMPARATORNo study-specific care will be provided to these participants.
Interventions
NECT-Y consists of 14 90-minute sessions over the course of 14 weeks. The intervention combines psychoeducation, cognitive therapy, narrative therapy, goal-setting and peer support. Each group meeting includes educational materials, reflections, and active exercises that participants are guided through to personalize the content to their experiences. Participants will be provided with a workbook which allows them to follow the activities easier.
Standard usual care. No study-specific care, but participants will be provided with information on community resources and support, and will also be encouraged to speak to their clinician if they are interested in learning about other services.
Eligibility Criteria
You may qualify if:
- Primary diagnosis of bipolar disorder (any subtype) OR diagnosed with multiple mental health conditions (excluding bipolar disorder)
- 'Mild' to 'severe' internalized stigma (mean score \> 2.0 on the Internalized Stigma of Mental Illness Inventory)
- Must sign and date the informed consent form
- Stated willingness to comply with all study procedures
You may not qualify if:
- Mental health-related hospitalization or emergency department visit in the last 30 days
- Initiation of a new psychotherapy in the last 30 days
- Inability to consent or to communicate in English
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Centre for Addiction and Mental Health
Toronto, Ontario, M6J1H4, Canada
Related Publications (2)
Hawke LD, Bennett R, Sheikhan NY, Yanos P. Lived experience adaptation of a psychosocial intervention for young adults with bipolar spectrum disorders: Process description and adaptation outcomes. Early Interv Psychiatry. 2023 Nov;17(11):1125-1130. doi: 10.1111/eip.13461. Epub 2023 Aug 31.
PMID: 37650493BACKGROUNDHawke LD, Husain MI, Amartey A, Ma C, Osuch E, Yanos PT, Gallagher L, Jordan A, Orson J, Lee A, Kozloff N, Kidd SA, Goldstein BI, Sheikhan NY, Ortiz A, Szatmari P. Narrative enhancement and cognitive therapy for self-stigma among youth with bipolar disorder or multiple mental health conditions: protocol for a pilot randomised basket trial. BMJ Open. 2025 Feb 26;15(2):e096222. doi: 10.1136/bmjopen-2024-096222.
PMID: 40010812DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Lisa Hawke, PhD
Centre for Addiction and Mental Health
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Masking Details
- Data analysts will be masked as to treatment arms.
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 1, 2024
First Posted
November 4, 2024
Study Start
November 1, 2024
Primary Completion
December 1, 2025
Study Completion
April 1, 2026
Last Updated
November 4, 2024
Record last verified: 2024-11
Data Sharing
- IPD Sharing
- Will share
Data will be placed in a local brain health data bank following institutional requirements.